共 141 条
The neurobiological basis of binge-eating disorder
被引:242
作者:
Kessler, Robert M.
[1
]
Hutson, Peter H.
[2
]
Herman, Barry K.
[2
]
Potenza, Marc N.
[3
,4
]
机构:
[1] Univ Alabama Birmingham, Dept Radiol, Sch Med, 619 19th St South, Birmingham, AL 35249 USA
[2] Shire, 300 Shire Way, Lexington, MA 02421 USA
[3] Yale Univ, CASAColumbia, Dept Psychiat, Dept Neurobiol,Child Study Ctr,Sch Med, 34 Pk St, New Haven, CT 06519 USA
[4] Yale Univ, Connecticut Mental Hlth Ctr, Sch Med, 34 Pk St, New Haven, CT 06519 USA
关键词:
Binge-eating disorder;
Cognition;
Reward;
Neuroimaging;
Compulsivity;
Impulsivity;
OPIOID RECEPTOR ANTAGONIST;
SEROTONIN TRANSPORTER BINDING;
DOPAMINE D2 RECEPTORS;
FOOD ADDICTION;
OBESE INDIVIDUALS;
BULIMIA-NERVOSA;
INHIBITORY CONTROL;
ENVIRONMENTAL-INFLUENCES;
REWARD-SENSITIVITY;
DECISION-MAKING;
D O I:
10.1016/j.neubiorev.2016.01.013
中图分类号:
B84 [心理学];
C [社会科学总论];
Q98 [人类学];
学科分类号:
03 ;
0303 ;
030303 ;
04 ;
0402 ;
摘要:
Relatively little is known about the neuropathophysiology of binge-eating disorder (BED). Here, the evidence from neuroimaging, neurocognitive, genetics, and animal studies are reviewed to synthesize our current understanding of the pathophysiology of BED. Binge-eating disorder may be conceptualized as an impulsive/compulsive disorder, with altered reward sensitivity and food-related attentional biases. Neuroimaging studies suggest there are corticostriatal circuitry alterations in BED similar to those observed in substance abuse, including altered function of prefrontal, insular, and orbitofrontal cortices and the striatum. Human genetics and animal studies suggest that there are changes in neurotransmitter networks, including dopaminergic and opioidergic systems, associated with binge-eating behaviors. Overall, the current evidence suggests that BED may be related to maladaptation of the corticostriatal circuitry regulating motivation and impulse control similar to that found in other impulsive/compulsive disorders. Further studies are needed to understand the genetics of BED and how neurotransmitter activity and neurocircuitry function are altered in BED and how pharmacotherapies may influence these systems to reduce BED symptoms. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgilicenses/by-nc-nd/4.0/).
引用
收藏
页码:223 / 238
页数:16
相关论文